Ghazaleh Bigdeli, MD
Critical Care Medicine · Youngstown, OHNPI 1003806134
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,630 of the $10,268 with a category attached, or 74.3%. It is spread thinly across 38 manufacturers, the largest accounting for just 23.9%. Reporting peaked in 2023 at $3,714 and has fallen 66.1% since, to $1,260 in 2025. Among critical care medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 339 payments — averaging $30.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Noah Medical Corporation$2K
- AstraZeneca$2K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$453
- United Therapeutics Corporation$446
- Boehringer Ingelheim$391
- plus $4K from 32 others
What the payments were for
- Travel & lodging$2,50324%
- Food & beverage$7,63074%
- Education$1341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Noah Medical Corporation | 13 | $2,451 |
| AstraZeneca | 65 | $1,713 |
| GSK | 81 | $1,058 |
| Regeneron Healthcare Solutions, Inc. | 17 | $453 |
| United Therapeutics Corporation | 11 | $446 |
| Boehringer Ingelheim | 18 | $391 |
| Sanofi | 10 | $327 |
| Jazz Pharmaceuticals Inc. | 7 | $259 |
| Merck | 9 | $255 |
| Amgen | 9 | $247 |
| Harmony Biosciences LLC | 12 | $230 |
| Olympus Corporation Of The Americas | 2 | $202 |
| Pulmonx Corporation | 3 | $198 |
| Actelion Pharmaceuticals US, Inc. | 7 | $198 |
| Mylan Specialty L.p. | 11 | $194 |
| Insmed, Inc. | 8 | $169 |
| Grifols USA, LLC | 9 | $160 |
| Johnson & Johnson | 1 | $138 |
| Mallinckrodt Hospital Products Inc. | 2 | $133 |
| Philips North America LLC | 2 | $110 |
| Intuitive Surgical | 1 | $98 |
| Novartis | 4 | $90 |
| Fisher & Paykel Healthcare Inc | 4 | $90 |
| Genentech USA, Inc. | 5 | $84 |
| Baxter Healthcare | 3 | $78 |
| Inspire Medical Systems, Inc. | 4 | $76 |
| Sunovion Pharmaceuticals Inc. | 5 | $62 |
| Electromed, Inc. | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Sanofi-aventis U.S. LLC | 1 | $46 |
| CSL Behring | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Mallinckrodt Enterprises LLC | 2 | $31 |
| Shionogi Inc | 1 | $26 |
| Shire North American Group Inc | 1 | $24 |
| Pfizer | 1 | $16 |
| Resmed Corp | 1 | $12 |
| Circassia Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$245
- Olympus EBUS Bronchoscopes$150
- Olympus Respiratory Accessories$150
- Olympus Capital Accessories$150
- Monarch Platform$138
- AIRSUPRA$135
- CHARTIS CATHETER$127
- ZEPHYR DELIVERY CATHETER$127
- ZEPHYR ENDOBRONCHIAL VALVE$127
- PULMONX CHARTIS TABLET CONSOLE$127
- XYWAV$125
- TEZSPIRE$123
- DUPIXENT$121
- ACTHAR$116
- ZERBAXA$112
- NUCALA$111
- UPTRAVI$108
- OPSUMIT$108
How this compares
$10,268 in reported general payments places this provider in the 95th percentile of 285 critical care medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 312 | $240,994 |
| OfevNintedanib Esylate | 21 | $172,938 |
| NucalaMepolizumab | 31 | $124,536 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 89 | $59,615 |
| Breo ElliptaFluticasone/Vilanterol | 121 | $54,817 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 85 | $48,045 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 51 | $26,172 |
| Spiriva RespimatTiotropium Bromide | 27 | $18,338 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $10,881 |
| DuleraMometasone/Formoterol | 21 | $10,408 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 18 | $10,319 |
| EliquisApixaban | 14 | $9,146 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $9,039 |
| Arformoterol Tartrate | 12 | $8,443 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 265 | $7,090 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $1,058 | $474,474562 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat, Combivent Respimat | $391 | $227,767117 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,713 | $68,654115 claims |
| MerckDulera | $255 | $10,40821 claims |
| PfizerEliquis | $16 | $9,14614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 285 critical care medicine providers in Ohio.
Other critical care medicine in Youngstown
- Basanta MohapatraYoungstown$2K
- Neal ChaissonCleveland$428K
- Robert SchilzCleveland$356K
- Nicholas PastisColumbus$145K
- Michael EssandohColumbus$135K
- Chiedozie UdehCleveland$24K
- Kari GorderColumbus$20K
- Elliott CrouserColumbus$16K
- Sadia BenzaquenCincinnati$15K
- Lawrence GoldsteinBoardman$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.